These networks reveal the importance of the therapeutic modulation of PI3K/AKT/MTOR, ETV7, and YAP/TAZ, as they alter several oncogenes and cellular pathways and that can cause several diseases (including breast cancer); details given below. This evidence concerns the gene MTOR and breast cancer.